209 related articles for article (PubMed ID: 15535246)
21. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
[TBL] [Abstract][Full Text] [Related]
22. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma.
Salvesen HB; MacDonald N; Ryan A; Jacobs IJ; Lynch ED; Akslen LA; Das S
Int J Cancer; 2001 Jan; 91(1):22-6. PubMed ID: 11149415
[TBL] [Abstract][Full Text] [Related]
23. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
[TBL] [Abstract][Full Text] [Related]
24. Molecular genetic characterization of tamoxifen-associated endometrial cancer.
Prasad M; Wang H; Douglas W; Barakat RR; Ellenson LH
Gynecol Oncol; 2005 Jan; 96(1):25-31. PubMed ID: 15589576
[TBL] [Abstract][Full Text] [Related]
25. [Biology of endometrial cancer].
Fujita M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():264-8. PubMed ID: 15535248
[No Abstract] [Full Text] [Related]
26. Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia.
Orbo A; Nilsen MN; Arnes MS; Pettersen I; Larsen K
Int J Gynecol Pathol; 2003 Apr; 22(2):141-8. PubMed ID: 12649668
[TBL] [Abstract][Full Text] [Related]
27. Considerations when analyzing the methylation status of PTEN tumor suppressor gene.
Zysman MA; Chapman WB; Bapat B
Am J Pathol; 2002 Mar; 160(3):795-800. PubMed ID: 11891178
[TBL] [Abstract][Full Text] [Related]
28. hMLH1 promoter hypermethylation in microsatellite instability-positive endometrial carcinoma. Cause or consequence?
Ellenson LH
Am J Pathol; 1999 Nov; 155(5):1399-402. PubMed ID: 10550292
[No Abstract] [Full Text] [Related]
29. Allelic imbalances in endometrial stromal neoplasms: frequent genetic alterations in the nontumorous normal-appearing endometrial and myometrial tissues.
Moinfar F; Kremser ML; Man YG; Zatloukal K; Tavassoli FA; Denk H
Gynecol Oncol; 2004 Dec; 95(3):662-71. PubMed ID: 15581979
[TBL] [Abstract][Full Text] [Related]
30. Unfavorable prognostic factors associated with high frequency of microsatellite instability and comparative genomic hybridization analysis in endometrial cancer.
Hirasawa A; Aoki D; Inoue J; Imoto I; Susumu N; Sugano K; Nozawa S; Inazawa J
Clin Cancer Res; 2003 Nov; 9(15):5675-82. PubMed ID: 14654551
[TBL] [Abstract][Full Text] [Related]
31. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas.
Strazzullo M; Cossu A; Baldinu P; Colombino M; Satta MP; Tanda F; De Bonis ML; Cerase A; D'Urso M; D'Esposito M; Palmieri G
Cancer; 2003 Oct; 98(7):1540-6. PubMed ID: 14508843
[TBL] [Abstract][Full Text] [Related]
32. [PTEN--a new tumor inhibitory gene].
Tian X; Wu H
Zhonghua Bing Li Xue Za Zhi; 2000 Dec; 29(6):455-7. PubMed ID: 12790140
[No Abstract] [Full Text] [Related]
33. PTEN mutations and evolving concepts in endometrial neoplasia.
Latta E; Chapman WB
Curr Opin Obstet Gynecol; 2002 Feb; 14(1):59-65. PubMed ID: 11801878
[TBL] [Abstract][Full Text] [Related]
34. Methylation of hMLH1 in a population-based series of endometrial carcinomas.
Salvesen HB; MacDonald N; Ryan A; Iversen OE; Jacobs IJ; Akslen LA; Das S
Clin Cancer Res; 2000 Sep; 6(9):3607-13. PubMed ID: 10999752
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
36. BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers.
Miturski R; Bogusiewicz M; Tarkowski R; Ciotta C; Bignami M; Burnouf D; Jakowicki JA
Oncol Rep; 2003; 10(4):1039-43. PubMed ID: 12792767
[TBL] [Abstract][Full Text] [Related]
37. Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma.
Pallares J; Martínez-Guitarte JL; Dolcet X; Llobet D; Rue M; Palacios J; Prat J; Matias-Guiu X
J Pathol; 2004 Dec; 204(5):569-77. PubMed ID: 15481028
[TBL] [Abstract][Full Text] [Related]
38. [Molecular mechanisms in endometrial carcinoma].
Nakao Y; Iwasaka T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():248-53. PubMed ID: 15535245
[No Abstract] [Full Text] [Related]
39. [Involvement of phosphoinositide 3-kinases and phosphoinositide phosphatases in immune responses, glucose metabolism and tumorigenesis].
Sasaki T; Sasaki J; Suzuki A; Penninger JM
Tanpakushitsu Kakusan Koso; 2001 Sep; 46(12):1820-9. PubMed ID: 11552264
[No Abstract] [Full Text] [Related]
40. Conference report - apoptosis - a graceful death: highlights from the 2003 Annual Meeting of the American Association for Cancer Research; July 11-14, 2003; Washington, DC.
Mariani SM
MedGenMed; 2003 Oct; 5(4):4. PubMed ID: 14745351
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
